Insiders · FSII

Daniel Dubin

Director at Pardes Biosciences, Inc. (FSII)

Daniel Dubin has filed 2 insider reports with the SEC since December 2021, as director at Pardes Biosciences, Inc. (FSII). The latest filing, on December 30, 2021, reports conversion of a derivative at Pardes Biosciences, Inc. (FSII).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Daniel Dubin is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Pardes Biosciences, Inc. logo
FSII
Pardes Biosciences, Inc.
Director30,000Dec 30, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Daniel Dubin with

Questions about Daniel Dubin

What is Daniel Dubin's role at Pardes Biosciences, Inc.?
Daniel Dubin reports to the SEC as director at Pardes Biosciences, Inc. (FSII), according to the latest filing on December 30, 2021.
How many shares does Daniel Dubin own?
After the latest filing that states it, Daniel Dubin directly owned 30,000 shares of Pardes Biosciences, Inc. (FSII). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Daniel Dubin bought or sold stock recently?
No open-market purchases or sales by Daniel Dubin are on file. The filings report conversion of a derivative.
How do I get alerts when Daniel Dubin files?
Follow Daniel Dubin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Daniel Dubin (SEC CIK 0001820809). Totals count each trade once, skipping amendments whose original is on file, from Dec 28, 2021 on. View on SEC EDGAR · Get this as JSON